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Background:  Given the limited published data, we sought to describe the long-term clinical follow-up of patients treated with device 
closure for secundum atrial septal defects (ASD).
methods:  All patients undergoing percutaneous ASD closure in the adult cardiac catheterization lab at Duke between 2002 and 2014 were 
identified. The clinical characteristics, procedural details, and late outcomes were defined for each patient.
results:  Between 2002 and 2014, 213 patients underwent ASD closure at a median age of 51 yrs (IQR- interquartile range: 40 yrs., 66 
yrs.). Patients were selected based on pre-procedure anatomy defined by echo and cardiac magnetic resonance imaging (CMR). Devices 
used included Amplatzer ASO, Gore Helex, and Amplatzer Cribriform in 172 (81%), 34 (16%), and 7 (3%) patients, respectively. One 
device embolization occurred on post-procedure day 1 treated with surgical removal and closure. After a median follow-up of 7.2 (IQR: 4.1, 
9.4) years, 18 (8.5%) died with a median duration between implantation and death of 3.3 (IQR: 1.6, 4.9) years. There was no procedural 
mortality or late device embolization or erosion. Three (1.4%) patients died within 1 year of the procedure. One, five, and ten year survival 
rates were 98.6% (97.0%, 100%), 92.7% (89.1%, 96.5%), and 90.0% (85.7%, 94.6%) respectively.
Conclusion:  Transcatheter ASD closure, employing pre-procedure anatomic selection with CMR, can be accomplished with low 
procedural risk and is associated with favorable long term outcome.
